… Molnupiravir is a newer oral antiviral drug that has recently been tested in COVID-19. We
aim to … of literature to find out the efficacy and safety of molnupiravir in patients with COVID-19. …

… First, due to the limited published data about the use of molnupiravir in COVID-19, more data
are needed to support the application of molnupiravir in the treatment of COVID-19. Second…

… of treatment with molnupiravir started … Covid-19 and at least one risk factor for severe
Covid-19 illness. Participants in the trial were randomly assigned to receive 800 mg of molnupiravir …

… of molnupiravir to reduce replication of SARS-CoV-2 and accelerate clearance of infectious
virus and support ongoing trials of molnupiravir to prevent progression of COVID-19 and …

… Molnupiravir recently granted the FDA emergency use authorization to treat mild to
moderate COVID-19 … the mechanism of Molnupiravir-induced COVID-19 mutagenesis. This …

… received Emergency Use Authorization in three countries for the treatment of mild COVID-19.
The aim of this systematic review was to find out the safety and efficacy of Molnupiravir in …

… research progress of molnupiravir starting with its … molnupiravir are also summarized and
discussed, aiming to expand our knowledge on molnupiravir and better deal with the COVID-19 …

… In conclusion, our study supports the use of molnupiravir in non-hospitalized patients with
COVID-19. Further research should be focused on evaluating its comparative efficacy in …

… molnupiravir in patients hospitalized with Covid-19. … The favorable safety and tolerability
profile of molnupiravir seen … The potential of molnupiravir as an antiviral treatment for Covid-19 …

… of COVID-19, the molnupiravir development program moved to the treatment of COVID-19
[… However, at present, molnupiravir looks a foreseeable treatment for COVID-19 that may be …